Evaluation of efficacy and safety of Platlet-Rich Plasma
Phase 2
Recruiting
- Conditions
- disorders of tendon attachment and ligament injurytendinitis, tendinopathy, ligament injury
- Registration Number
- JPRN-jRCTc030190102
- Lead Sponsor
- Funasaki Hiroki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients who have disorders of tendon attachment and ligament injury.
Patients who have written an informed consent.
Patients who have no bacterial infection.
Patients who are over 20 years old men and women.
Exclusion Criteria
Patients who have bacterial infection including the injection site.
Patients who have a risk of affecting their general health in case of bacterial infection by this therapy.
Patients who have over 37 degrees of body temperature without using antipyretic or anti-inflammatory.
Patients who have open wound.
Patients who undergo an oral treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physical findings, Visual Analog Scale and return scale
- Secondary Outcome Measures
Name Time Method Occurrence of complication